CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Clinical Implications of Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion: Role of Antegrade and Retrograde Crossing Techniques Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents Coronary Catheterization and Percutaneous Coronary Intervention in China: 10-Year Results From the China PEACE-Retrospective CathPCI Study 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media

Guideline2016 Sep 27;68(13):1476-1488.

JOURNAL:J Am Coll Cardiol. Article Link

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure

Yancy CW, Jessup M, Bozkurt B et al. Keywords: ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; heart failure; ivabradine; natriuretic peptides

Full Text PDF